Skip to main content

Diagnostic options Β· UAE

Genetic Hearing Loss tests in Dubai & UAE

Compare available Genetic Hearing Loss tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

8

Listed price range

2,800.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetic Hearing Loss test prices

Showing 1–8 of 8 matching tests.

Genetic Hearing Loss diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-5769
ACTG1 Gene Autosomal Dominant Deafness Type 20 (DFNA20) Genetic Test

This test identifies pathogenic variants in the ACTG1 gene associated with autosomal dominant nonsyndromic sensorineural hearing loss (DFNA20/26).

Peripheral whole blood 21–28 Business Days 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the ACTG1 gene", "Single nucleotide variants", "Small insertions and deletions", "Copy number alterations"]
Parameters
[]
Preparation
["No fasting required", "Stay well hydrated", "Avoid dietary supplements 24 hours before collection", "Inform phlebotomist of all medications", "Mandatory pre-test genetic counselling session"]
Indications
["Diagnosis of autosomal dominant nonsyndromic sensorineural hearing loss", "Genetic counselling for families with hearing loss", "Family planning"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21636-6 ICD-10: H90.3
Clinical summary
This test identifies pathogenic variants in the ACTG1 gene associated with autosomal dominant nonsyndromic sensorineural hearing loss (DFNA20/26).
TEST-5715
COL11A2 Gene Deafness, Autosomal Dominant Type 13 Genetic Test

This genetic test evaluates the COL11A2 gene for mutations associated with autosomal dominant nonsyndromic hearing loss type DFNA13.

Peripheral Whole Blood 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["COL11A2 gene sequence", "Point mutations", "Insertions/Deletions (Indels)", "Copy Number Variations (CNV)"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab of any medications"]
Indications
["Individuals with progressive sensorineural hearing loss", "Family history suggestive of autosomal dominant hearing loss", "Genetic confirmation for treatment guidance", "Family planning", "Cascade screening of relatives"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 95156-8 ICD-10: H90.5
Clinical summary
This genetic test evaluates the COL11A2 gene for mutations associated with autosomal dominant nonsyndromic hearing loss type DFNA13.
TEST-5683
HGF Gene Deafness, Autosomal Recessive Type 39 Genetic Test

This test identifies pathogenic variants within the HGF gene associated with autosomal recessive sensorineural hearing loss type 39.

Whole Blood (Peripheral), Extracted DNA, or Dried Blood Spot (FTA Card) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the HGF gene", "Coding regions and splice sites of the HGF gene"]
Parameters
[]
Preparation
["No special dietary restrictions or fasting required", "Do not discontinue prescribed medications without consulting your physician"]
Indications
["Diagnosis of autosomal recessive deafness type 39", "Genetic counseling for families with hearing loss"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21631-6 ICD-10: H90.3
Clinical summary
This test identifies pathogenic variants within the HGF gene associated with autosomal recessive sensorineural hearing loss type 39.
TEST-5609
LRTOMT Gene Deafness, Autosomal Recessive Type 63 Genetic Test

This genetic test detects biallelic mutations in the LRTOMT gene, which are the cause of autosomal recessive deafness type 63 (DFNB63).

Whole blood (EDTA) or DNA FTA card 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Biallelic mutations in the LRTOMT gene", "Presence of pathogenic variants associated with DFNB63"]
Parameters
[]
Preparation
["Fasting is not required", "No special preparation needed"]
Indications
["Diagnosis of non-syndromic hearing loss", "Carrier screening in families with a history of DFNB63", "Genetic counseling for families affected by hearing loss"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81245-0 ICD-10: H90.5, H90.3
Clinical summary
This genetic test detects biallelic mutations in the LRTOMT gene, which are the cause of autosomal recessive deafness type 63 (DFNB63).
TEST-5613
MYH7B Genetic Hearing Loss NGS Test

This test identifies pathogenic variants within the MYH7B gene associated with autosomal dominant non-syndromic sensorineural hearing loss.

Whole Blood (3–5 mL EDTA tube), Extracted DNA, or FTA Card 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["MYH7B gene pathogenic variants", "Copy Number Variations (CNVs) in MYH7B"]
Parameters
[]
Preparation
["No fasting required"]
Indications
["Individuals with a family history of early-onset deafness", "Progressive sensorineural hearing loss of unknown origin", "Confirmation of suspected MYH7B-related hearing loss"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 101325-0 ICD-10: H90.3
Clinical summary
This test identifies pathogenic variants within the MYH7B gene associated with autosomal dominant non-syndromic sensorineural hearing loss.
TEST-5602
PNPT1 Gene Autosomal Recessive Deafness Type 70 (DFNB70) Genetic Test

This test evaluates the PNPT1 gene for pathogenic variants associated with autosomal recessive non-syndromic hearing loss (DFNB70). It uses Next-Generation Sequencing (NGS) and cop...

Peripheral whole blood (3–5 mL in EDTA tube) 3–4 Weeks (optional express 2-week upgrade) 2,800.00 AED
View
View test specifications and preparation
What it measures
["PNPT1 gene sequence", "PNPT1 gene copy number variations"]
Parameters
[]
Preparation
[]
Indications
["Diagnosis of suspected DFNB70", "Guiding cochlear implantation decisions", "Family cascade screening", "Recurrence risk counseling"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94854-8 ICD-10: H90.5
Clinical summary
This test evaluates the PNPT1 gene for pathogenic variants associated with autosomal recessive non-syndromic hearing loss (DFNB70). It uses Next-Generation Sequencing (NGS) and copy number variation (CNV) detection.
TEST-5645
RDX Gene Deafness (Autosomal Recessive Type 24) Genetic Test

This genetic test identifies pathogenic variants in the RDX gene associated with autosomal recessive non-syndromic hearing loss type 24.

Peripheral Whole Blood (EDTA) or Buccal Swab (DNA) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the RDX gene"]
Parameters
[]
Preparation
["No fasting required", "Inform phlebotomist of bleeding disorders or anticoagulant use"]
Indications
["Suspected autosomal recessive non-syndromic hearing loss type 24 (DFNB24)"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21659-6 ICD-10: H90.3
Clinical summary
This genetic test identifies pathogenic variants in the RDX gene associated with autosomal recessive non-syndromic hearing loss type 24.
TEST-5614
TMIE Gene Deafness, Autosomal Recessive Type 6 Genetic Test

This diagnostic test evaluates the TMIE gene for pathogenic variants associated with autosomal recessive deafness type 6 (DFNB6). It identifies mutations causing congenital or earl...

Whole Blood (EDTA), Extracted DNA, or FTA card sample 3 – 4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the TMIE gene", "Single nucleotide variants", "Small indels", "Copy number variants"]
Parameters
[]
Preparation
["No specific fasting required", "Inform phlebotomist of bleeding disorders or severe anaemia"]
Indications
["Diagnosis of autosomal recessive deafness type 6 (DFNB6)", "Genetic counselling for families with hearing loss", "Informing family planning and early intervention strategies"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 58122-8 ICD-10: H90.3
Clinical summary
This diagnostic test evaluates the TMIE gene for pathogenic variants associated with autosomal recessive deafness type 6 (DFNB6). It identifies mutations causing congenital or early-onset sensorineural hearing loss.

Category overview

Genetic Hearing Loss: overview

When a family history of deafness points toward a specific hereditary trait, getting precise molecular confirmation is crucial for proactive medical management and family planning. As an essential diagnostic tool within our Molecular Genetics services, Genetic Hearing Loss testing specifically targets the DNA mutations responsible for your family's unique auditory challenges. By leveraging cutting-edge diagnostic technology, this precise genomic screening provides the definitive data needed to assess carrier status, evaluate risks for future children, and safely guide tailored pediatric audiology interventions like cochlear implants. Consistently trusted by ENTs across premier diagnostic labs in Dubai and the UAE, DNA Labs ensures strict patient confidentiality, exceptional analytical precision, and prompt, reliable reporting. Protect your family's sensory futureβ€”book your genetic hearing loss testing in UAE, arrange a comfortable home sample collection, or consult our dedicated genetic counselors today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.